Company Description
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.
The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.
Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.
The company was founded in 1997 and is headquartered in Long Beach, California.
| Country | United States |
| Founded | 1997 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| Employees | 881 |
| CEO | Ms. Marla Malcolm Beck |
Contact Details
Address: 2165 Spring Street Long Beach, California 90806 United States | |
| Phone | 800-603-4996 |
| Website | beautyhealth.com |
Stock Details
| Ticker Symbol | SKIN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001818093 |
| CUSIP Number | 88331L108 |
| ISIN Number | US88331L1089 |
| Employer ID | 85-1908962 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Marla Malcolm Beck | President, Chief Executive Officer and Director |
| Daniel Copell Watson | Chief Revenue Officer |
| Michael P. Monahan | Chief Financial Officer |
| Sheri Lewis | Chief Supply Chain and Operations Officer |
| Eduardo Rodriguez | Senior Director of M&A and Investor Relations |
| Paul Bokota | Vice President and General Counsel |
| Celeste Ortiz | Chief Human Resources Officer |
| Mingo Ku | President of APAC |
| Jon Arnold | President of EMEA |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 10, 2024 | PRE 14A | Other preliminary proxy statements |
| Apr 9, 2024 | 8-K | Current Report |
| Apr 8, 2024 | 8-K | Current Report |
| Apr 5, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Mar 14, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Mar 12, 2024 | 10-K | Annual Report |
| Mar 12, 2024 | 8-K | Current Report |
| Mar 12, 2024 | 8-K | Current Report |
| Feb 29, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |